fbpx

molecules of the month

PF-6870961

GHSR1a inverse agonist (metabolite of oral molecule)

Ph. Ia for heavy alcohol drinking

major hydroxy metabolite of PF-5190457

JPET, January 11, 2023

NIDA/NIAAA, NIH (Pfizer)

6 mins read

A metabolite and its parent: same target inhibition, different mechanisms. PF-6870961 is a growth hormone secretagogue receptor 1a (GHSR1a) inverse agonist biased for inhibition of 𝜷-arrestin signaling, in contrast to its parent compound, PF-5190457, an unbiased GHSR1a inverse agonist. PF-6870961 was discovered as a major metabolite of PF-5190457 by Pfizer during the analysis of sera from patients in Ph. Ib for heavy alcohol drinking (NCT02039349). Then, in preclinical rodent models and initial human studies, the metabolite was found to have an effect on food intake and craving. This case study serves as an interesting example of a metabolite with comparable potency to its parent, but acts through a different mechanism of action of 𝜷-arrestin-biased inverse agonism. Metabolite PF-6870961 more potently…


request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.


already a member? log in: